Biogen Inc.
BIIB · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $467 | $635 | $241 | $267 |
| Dep. & Amort. | $202 | $194 | $183 | $184 |
| Deferred Tax | $254 | -$31 | -$28 | -$58 |
| Stock-Based Comp. | $75 | $75 | $81 | $75 |
| Change in WC | $174 | -$790 | -$334 | $28 |
| Other Non-Cash | $101 | $78 | $116 | $265 |
| Operating Cash Flow | $1,273 | $161 | $259 | $761 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$52 | -$27 | -$47 | -$66 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$91 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $57 | $0 | $0 | -$41 |
| Other Inv. Act. | $51 | -$30 | -$0 | $88 |
| Investing Cash Flow | -$35 | -$57 | -$47 | -$19 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$0 | -$17 | $0 | $0 |
| Stock Issued | $5 | $6 | -$24 | $4 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$135 | -$1 | $1 | $4 |
| Financing Cash Flow | -$130 | -$12 | -$23 | $8 |
| Forex Effect | -$3 | $68 | $34 | -$74 |
| Net Chg. in Cash | $1,104 | $161 | $223 | $676 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,759 | $2,598 | $2,375 | $1,699 |
| End Cash | $3,863 | $2,759 | $2,598 | $2,375 |
| Free Cash Flow | $1,226 | $144 | $212 | $695 |